Enhancing Spermatogenesis in Non-obstructive Azoospermia Through Mesenchymal Stem Cell Therapy22

Area of Science:

• Regenerative Medicine
• Reproductive Biology
• Cell Therapy

Background:

• Male infertility, particularly azoospermia, affects a significant portion of the global population.
• Non-obstructive azoospermia (NOA) presents a major challenge in male reproductive health.
• Stem cell therapy offers potential for tissue regeneration and treatment of degenerative disorders.

Purpose of the Study:

• To review the therapeutic potential of mesenchymal stem cells (MSCs) for treating non-obstructive azoospermia (NOA).
• To explore the role of MSCs and their extracellular vesicles in spermatogenesis and germ cell regeneration.
• To summarize current findings from animal models regarding MSC-based therapies for NOA.

Main Methods:

• Review of existing literature on stem cell therapy, mesenchymal stem cells, and azoospermia treatment.
• Analysis of studies investigating MSC differentiation into germ cells in animal models.
• Examination of research on extracellular vesicles derived from MSCs for spermatogenesis enhancement.

Main Results:

• Mesenchymal stem cells (MSCs) demonstrate the ability to differentiate into germ cells and improve spermatogenesis in animal models.
• Extracellular vesicles derived from MSCs have shown efficacy in stimulating germ cell regeneration in recipient testes in animal studies.
• Despite promising results in animal models, no clinical trials have yet investigated MSC therapy for NOA in humans.

Conclusions:

• Mesenchymal stem cells (MSCs) and their extracellular vesicles represent a promising avenue for novel therapeutic strategies targeting non-obstructive azoospermia (NOA).
• Further research and clinical trials are warranted to evaluate the safety and efficacy of MSC transplantation for treating male infertility caused by NOA.